Results 241 to 250 of about 413,185 (307)

Autologous SVF therapy modulates neuroinflammation in ALS: phase I trial demonstrating safety and CSF biomarker dynamics. [PDF]

Front Aging Neurosci
Li R, Wang L, Bu W, Zhang X, Li X, Li J, Shen J, Li J, Cai Z.   +8 more
europepmc   +1 more source

A multilevel perspective on MSH6‐associated Lynch syndrome: Integrating molecular, biological, and clinical insights

International Journal of Cancer, EarlyView.
Abstract Lynch syndrome (LS) is the most common hereditary colorectal cancer syndrome, caused by a germline pathogenic variant in one of the mismatch repair (MMR) genes. Among these, MSH6‐associated LS represents a distinct subtype with unique molecular and clinical characteristics.
Salwa Ben Yahia, Anne‐Sophie van der Werf‐'t Lam, Madalina Cabuta, Maartje Nielsen, Noah C. Helderman   +4 more
wiley   +1 more source

The Safety, Efficacy, and Feasibility of Fecal Microbiota Transplantation in a Population With Bipolar Disorder During Depressive Episodes: A Pilot Parallel Arm Randomized Controlled Trial: Sécurité, efficacité et faisabilité de la transplantation de microbiote fécal chez une population atteinte de troubles bipolaires, au cours d'épisodes dépressifs : essai pilote contrôlé à répartition aléatoire et à groupes parallèles. [PDF]

Can J Psychiatry
Shekarriz S, Vigod SN, Bianco T, Bala A, Hao C, Allard JP, Hota S, Poutanen S, Surette MG, Taylor VH.   +9 more
europepmc   +1 more source

Efficacy and Safety Profile of a Rituximab, Methotrexate, and Thiotepa‐Based Regimen in Newly Diagnosed Primary CNS Lymphoma

International Journal of Cancer, EarlyView.
Primary central nervous system diffuse large B‐cell lymphoma (PCNS‐DLBCL) lacks an optimal first‐line induction strategy, particularly for older patients and those ineligible for intensive consolidation. In this retrospective cohort of 36 newly diagnosed patients, the rituximab + methotrexate + thiotepa (RMT) regimen as first‐line induction achieved ...
Haotian Wang, Jia Li, Luming Cao, Ying Zhang, Xin Wan, Xingtong Wang, Yangzhi Zhao, Zhaoxia Li, Chengqian Chen, Yang Song, Ou Bai   +10 more
wiley   +1 more source

Evolving therapeutic pipeline for tumor-infiltrating lymphocytes in metastatic melanoma - a review. [PDF]

Front Immunol
Wu JF, Abid MA, Singh SP, Mohlere V, Abid MB.   +4 more
europepmc   +1 more source

Quantification and characterization of collagen in experimentally induced wounds treated with different types of platelet-rich plasma gel. [PDF]

Cell Tissue Bank
de Melo GH, Moreira FM, Mori GG, Bento LF, Barrionuevo DV, Laposy CB, Giuffrida R, Rodrigues AFF, Ozaki GAT, da Silva DAF, Pacagnelli FL, Nogueira RMB.   +11 more
europepmc   +1 more source

Matrix-induced autologous chondrocytes implantation for a large iatrogenic osteochondral defect of the knee: A case report. [PDF]

Trauma Case Rep
Osorno-Aimar OA, Lara-Palazuelos N, Valladares N, Zavala-Cerna MG.   +3 more
europepmc   +1 more source

Global Panoramic analysis of clinical research in cell therapy: clinical trial landscape, marketed products, and regulatory trends. [PDF]

Front Pharmacol
Wang M, Zhou T, Liu S, Xiang W, Xie K, Zhang X, Hu W, Fang M, Zhang Z, Chen M, Wang X, Wu J.   +11 more
europepmc   +1 more source

Correction: Autologous P63+ lung progenitor cell transplantation in idiopathic pulmonary fibrosis: a phase 1 clinical trial.

Elife
Zhang S, Zhou M, Shao C, Zhao Y, Liu M, Ni L, Bao Z, Zhang Q, Zhang T, Luo Q, Qu J, Xu Z, Zuo W.   +12 more
europepmc   +1 more source